Gland Pharma Ltd.

NSE: GLAND | BSE: 543245 | ISIN: INE068V01023 | Industry: Pharmaceuticals
| Mid-range Performer

logo
Gland Pharma Ltd.
09 Aug 2023
1736.10
2.75%
Axis Direct
Injectable companies (HIKMA, HOSIPORA, and Aurobindo) in the US market reported sales growth of ~4% YoY. We expect similar growth for GLAND in the core markets over a longer period and high single-digit growth in India and RoW over a long-term.
Gland Pharma Ltd. has an average target of 1710.00 from 2 brokers.
More from Gland Pharma Ltd.
Recommended